A Search Service for Abbreviation / Long Form

■検索結果 - 略語 : RANKL

検索条件

検索語：RANKL

検索方法：完全一致

主な研究分野:

結果

略語: RANKL

出現頻度: 6063

対応する展開形の数: 31

No.

展開形

主な研究分野

共起略語

PubMed/MEDLINE情報 (発表年, 題目)

receptor activator of NF-kappaB ligand

(骨芽細胞が発現するサイトカイン) 破骨細胞分化因子, NFκB活性化受容体リガンド

(5629回)

Dentistry

歯学

(579回)

OPG(1847回)

TRAP(674回)

M-CSF(457回)

1998Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.

RANK ligand

(破骨細胞の分化促進因子) RANKリガンド, ランクリガンド

(386回)

Neoplasms

新生物, 腫瘍

(59回)

RANK(231回)

OPG(176回)

TRAP(20回)

1997A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

RANK-RANK ligand

(7回)

Metabolism

代謝, 代謝作用, 新陳代謝, 物質代謝

(2回)

RANK(4回)

AS(1回)

AZURE(1回)

2010Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis.

RANK and its ligand

(6回)

Urology

泌尿器科学

(1回)

OPG(2回)

RANK(2回)

AIRE(1回)

2006Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.

receptor of NF-kappaB ligand

(3回)

Chemistry

化学

(1回)

BRONJ(1回)

IL-1beta(1回)

M-CSF(1回)

2011Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.

anti-RANK ligand

(3回)

Endocrinology

内分泌学

(1回)

GHD(1回)

NAFLD(1回)

NASH(1回)

2015Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review.

receptor activator ligand kbeta

(2回)

Chemistry

化学

(1回)

MSC(1回)

MSCs(1回)

PPARgamma(1回)

2023B. abortus Infection Promotes an Imbalance in the Adipocyte-Osteoblast Crosstalk Favoring Bone Resorption.

receptor activator of nuclear factor kappaB ligand to osteoprotegerin

(2回)

Rheumatology

リウマチ学

(1回)

M-CSF(1回)

micro-CT(1回)

ORN(1回)

2008Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.

osteoclastogenesis-related cytokines

(2回)

Dentistry

歯学

(2回)

IL(1回)

miR-146a(1回)

muCT(1回)

2016Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review.

relative expression of nuclear factor kappa-B ligand

(2回)

Biochemistry

生化学, 生物化学

(1回)

DMM(1回)

DNMT3A(1回)

GAA(1回)

2022Ganoderic acid A improves osteoarthritis by regulating RANKL/OPG ratio.

receptor activator of nuclear transcription factor-kappaB

(1回)

Metabolism

代謝, 代謝作用, 新陳代謝, 物質代謝

(1回)

MIP(1回)

VEGF(1回)

2002Role of the bone marrow microenvironment in multiple myeloma.

receptor activator of nuclear factor small ka, CyrillicB ligand

(1回)

Dentistry

歯学

(1回)

ALP(1回)

OPG(1回)

2008Cementoblast response to low- and high-intensity ultrasound.

receptor of nuclear factor kB

(1回)

Neoplasms

新生物, 腫瘍

(1回)

OC(1回)

2009Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients.

receptor of activator of NF(Kappa)B ligand receptor

(1回)

Medicine

医学, 医薬

(1回)

BAP(1回)

BMD(1回)

OPG(1回)

2007Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.

Receptor Activator of Nuclear factor Kappa B Receptor

(1回)

Medicine

医学, 医薬

(1回)

hMSCs(1回)

2015Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells.

RANKL, TRANCE, ODF

(1回)

Rheumatology

リウマチ学

(1回)

2002Role of RANKL and RANK in bone loss and arthritis.

Recently, nuclear factor kappa-beta ligand

(1回)

Neoplasms

新生物, 腫瘍

(1回)

NPC(1回)

PRaG(1回)

2025

RANKL-overexpressing LNCaP PCa cell line, LNCaP

(1回)

Neoplasms

新生物, 腫瘍

(1回)

PCa(1回)

2014Induction of integrin alpha2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.

RANK and its ligand TRANCE

(1回)

Allergy and Immunology

アレルギー・免疫

(1回)

htSNPs(1回)

T1D(1回)

TDT(1回)

2004Cost-effective analysis of candidate genes using htSNPs: a staged approach.

RANKL Tg

(1回)

Metabolism

代謝, 代謝作用, 新陳代謝, 物質代謝

(1回)

BMMPhis(1回)

DPH(1回)

LPS(1回)

2009Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.